Top Markets
Coin of the day
Scandion Oncology A/S Scandion Oncology A/S

Scandion Oncology A/S

SCOL
Kedudukan dalam Saham #40631
Operating as a clinical-stage biotechnology company, Scandion Oncology A/S... Operating as a clinical-stage biotechnology company, Scandion Oncology A/S specializes in creating pharmaceutical solutions to combat resistance to chemotherapy. Their primary investigational drug, SCO-101, an orally administered compound, is currently progressing through Phase Ib and Phase II clinical studies with cancer patients. Another pipeline candidate, SCO-201, is undergoing preclinical assessment for its potential efficacy against solid tumors. Established in 2017, Scandion Oncology A/S maintains its headquarters in Copenhagen, Denmark.
Harga Saham
$0.00045794
Disegerakkan terakhir: 2025-07-11
Modal Pasaran
$107.51K
Perubahan (1 hari)
-36.01%
Perubahan (1 tahun)
0.00%
Negara
DK
Perdagangan Scandion Oncology A/S (SCOL)

Kategori

Sejarah hasil dividen untuk Scandion Oncology A/S (SCOL)
Hasil dividen (TTM) bagi Scandion Oncology A/S (simbol saham: SCOL) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Scandion Oncology A/S (SCOL) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing